Circulating markers of prognosis and response to treatment in patients with midgut carcinoid tumours

G B Turner; B T Johnston; D R McCance; A McGinty; R G P Watson; C C Patterson; J E S Ardill

doi:10.1136/gut.2006.092320

Circulating markers of prognosis and response to treatment in patients with midgut carcinoid tumours

G B Turner
, B T Johnston
, D R McCance
, A McGinty
, R G P Watson
, C C Patterson
, J E S Ardill

Research output: Contribution to journal › Article › peer-review

108 Citations (Scopus)

Abstract

Midgut carcinoid tumours are uncommon tumours with an unpredictable clinical behaviour and few useful prognostic markers. Somatostatin analogues are widely used in treatment but a survival advantage has not been proven. We analysed features associated with poor prognosis and assessed the clinical implications of the biochemical response to therapy.

Original language	English
Pages (from-to)	1586-91
Number of pages	6
Journal	Gut
Volume	55
Issue number	11
DOIs	https://doi.org/10.1136/gut.2006.092320
Publication status	Published - Nov 2006

ASJC Scopus subject areas

Gastroenterology

Access to Document

10.1136/gut.2006.092320

Cite this

@article{c3fdd3796f984d01820b3a9bc1f96533,

title = "Circulating markers of prognosis and response to treatment in patients with midgut carcinoid tumours",

abstract = "Midgut carcinoid tumours are uncommon tumours with an unpredictable clinical behaviour and few useful prognostic markers. Somatostatin analogues are widely used in treatment but a survival advantage has not been proven. We analysed features associated with poor prognosis and assessed the clinical implications of the biochemical response to therapy.",

author = "Turner, \{G B\} and Johnston, \{B T\} and McCance, \{D R\} and A McGinty and Watson, \{R G P\} and Patterson, \{C C\} and Ardill, \{J E S\}",

year = "2006",

month = nov,

doi = "10.1136/gut.2006.092320",

language = "English",

volume = "55",

pages = "1586--91",

journal = "Gut",

issn = "0017-5749",

publisher = "BMJ Publishing Group",

number = "11",

}

TY - JOUR

T1 - Circulating markers of prognosis and response to treatment in patients with midgut carcinoid tumours

AU - Turner, G B

AU - Johnston, B T

AU - McCance, D R

AU - McGinty, A

AU - Watson, R G P

AU - Patterson, C C

AU - Ardill, J E S

PY - 2006/11

Y1 - 2006/11

N2 - Midgut carcinoid tumours are uncommon tumours with an unpredictable clinical behaviour and few useful prognostic markers. Somatostatin analogues are widely used in treatment but a survival advantage has not been proven. We analysed features associated with poor prognosis and assessed the clinical implications of the biochemical response to therapy.

AB - Midgut carcinoid tumours are uncommon tumours with an unpredictable clinical behaviour and few useful prognostic markers. Somatostatin analogues are widely used in treatment but a survival advantage has not been proven. We analysed features associated with poor prognosis and assessed the clinical implications of the biochemical response to therapy.

U2 - 10.1136/gut.2006.092320

DO - 10.1136/gut.2006.092320

M3 - Article

C2 - 16556667

SN - 0017-5749

VL - 55

SP - 1586

EP - 1591

JO - Gut

JF - Gut

IS - 11

ER -

Circulating markers of prognosis and response to treatment in patients with midgut carcinoid tumours

Abstract

ASJC Scopus subject areas

Access to Document

Fingerprint

Cite this